Nicolas Larmonier

CD4⁺CD25⁺ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

François Ghiringhelli, Nicolas Larmonier, E. Schmitt et al. · European Journal of Immunology · 2004 · 868 citations

Life Sciences, Immunology, Oncology +17

Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer

Darya Alizadeh, Malika Trad, Neale T. Hanke et al. · Cancer Research · 2013 · 409 citations · Full text

Medicine, Immunology, Oncology +17

CD4+CD25+FoxP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease

Xinchun Chen, Boping Zhou, Mei-zhong Li et al. · Clinical Immunology · 2007 · 281 citations

Life Sciences, Immunology, Infectious Diseases +12

Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis

Maxime Samson, Sylvain Audia, Jennifer Fraszczak et al. · Arthritis & Rheumatism · 2012 · 233 citations

Life Sciences, Immunology, Pathology +17

Tumor-derived CD4+CD25+ regulatory T cell suppression of dendritic cell function involves TGF-β and IL-10

Nicolas Larmonier, Marilyn Marron, Yi Zeng et al. · Cancer Immunology Immunotherapy · 2006 · 227 citations · Full text

Life Sciences, Immunology, Oncology +12